Publicaciones en las que colabora con Luis Alonso Pulpón Rivera (37)

2021

  1. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 149-158

2019

  1. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders

    Amyloid, Vol. 26, Núm. 3, pp. 156-163

2018

  1. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481

  2. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

  3. Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure

    Revista Espanola de Cardiologia, Vol. 71, Núm. 11, pp. 952-960

2017

  1. Expression of sterol regulatory element-binding proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: Preliminary study

    International Journal of Medical Sciences, Vol. 14, Núm. 3, pp. 268-274

2016

  1. Cancer Incidence in Heart Transplant Recipients with Previous Neoplasia History

    American Journal of Transplantation, Vol. 16, Núm. 5, pp. 1569-1578

  2. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 35, Núm. 5, pp. 625-635

2015

  1. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  2. Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42

2014

  1. The falling incidence of hematologic cancer after heart transplantation

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1142-1147

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

  2. Primary graft failure after heart transplantation: Characteristics in a contemporary cohort and performance of the radial risk score

    Journal of Heart and Lung Transplantation, Vol. 32, Núm. 12, pp. 1187-1195

2012

  1. Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers

    Revista Espanola de Cardiologia, Vol. 65, Núm. 1, pp. 22-28

2011

  1. Lung cancer after heart transplantation: Results from a large multicenter registry

    American Journal of Transplantation, Vol. 11, Núm. 5, pp. 1035-1040

2010

  1. Efecto de un programa de formación en atención primaria sobre la optimización del tratamiento con bloqueadores beta en pacientes ancianos con insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 63, Núm. 6, pp. 677-685

  2. Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 4

  3. The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: Data from the Spanish post-heart transplant tumour registry

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 3011-3013

2009

  1. Trasplante cardíaco

    Editorial Médica Panamericana

2008

  1. Benefit of neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction

    Transplantation, Vol. 85, Núm. 7, pp. 992-999